Expansion Target EyePACS has a broad footprint with over 600 organizations nationwide using its telemedicine and digital imaging for diabetic retinopathy screening, indicating strong scale and potential for expansion through integrated hospital networks and primary care clinics.

Acquisition Opportunity Recent news indicates Optain Health acquired EyePACS, suggesting a strategic exit or platform integration possibility. This could open conversations around continuity of service, data migration, and cross-sell of telemedicine imaging workflows.

Tech Stack Fit The company already leverages cloud and web-based technologies (AWS, Google Workspace, Cloudflare, PHP, DigitalOcean). This alignment signals receptiveness to deeply integrated SaaS solutions, security enhancements, and scalable data analytics partnerships.

Clinical Partnerships Longstanding collaborations with academic and clinical partners (UC Berkeley, UCSF Fresno, California Health Care Foundation) indicate a preference for validated, outcomes-driven programs, presenting opportunities for joint ventures or co-branded clinical studies.

Growth Readiness Revenue range of 1M to 10M and a patient-centric, cost-effective screening program positions EyePACS as a prime candidate for add-ons such as advanced imaging analytics, AI-assisted DR detection, and expanded telemedicine services across new markets.